1. Japan Stocks

  2. •

    Basic Materials

  3. •

    Chemicals
KNC Laboratories Co., Ltd.

KNC Laboratories Co., Ltd.

6568.T
KNC Laboratories Co., Ltd.JP flagTokyo Stock Exchange
1,328.00
JPY
-7.00
- -
10.28BMarket Cap

Total Valuation

KNC Laboratories Co., Ltd. carries a market capitalization of 10.28B, placing it among publicly traded companies globally. Its enterprise value stands at 8.38B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap10.28B
Enterprise Value8.38B

Share Statistics

KNC Laboratories Co., Ltd. currently has 7.73M shares outstanding.

Shares Outstanding7.73M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

KNC Laboratories Co., Ltd. trades at a trailing price-to-earnings ratio of 7.99. The price-to-sales ratio is 1.45, and the price-to-book ratio stands at 0.76.

PE Ratio7.99
PS Ratio1.45
PB Ratio0.76
P/TBV Ratio0.65
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, KNC Laboratories Co., Ltd. trades at an EV/EBITDA multiple of 5.76 and an EV/FCF ratio of 2,100.14. The EV/Sales ratio of 1.45 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 5.76 provides insight into valuation relative to core operating earnings.

EV / Sales1.45
EV / EBITDA5.76
EV / EBIT5.76
EV / FCF2,100.14

Financial Position

KNC Laboratories Co., Ltd. maintains a current ratio of 4.20, meaning it holds 4.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 15.17, indicating elevated leverage, while an interest coverage ratio of 263.14 demonstrates strong ability to service its debt obligations.

Current Ratio4.20
Quick Ratio1.29
Debt / Equity15.17
Debt / EBITDA1.36
Interest Coverage263.14

Financial Efficiency

KNC Laboratories Co., Ltd. posts a return on equity of 9.96 and a return on invested capital of 7.47.

Return on Equity (ROE)9.96
Return on Assets (ROA)6.69
Return on Invested Capital (ROIC)7.47
Return on Capital Employed (ROCE)8.83
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover1.22

Taxes

Over the trailing twelve months, KNC Laboratories Co., Ltd. has paid 405.01M in income taxes, reflecting an effective tax rate of 27.79.

Income Tax405.01M
Effective Tax Rate27.79

Stock Price Statistics

KNC Laboratories Co., Ltd.'s stock has gained approximately 24.11215% over the past 52 weeks. The 50-day moving average sits at 1,260.94, while the 200-day moving average is 1,205.55.

Beta (5Y)N/A
52-Week Price Change24.11215%
50-Day Moving Average1,260.94
200-Day Moving Average1,205.55
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, KNC Laboratories Co., Ltd. generated 5.78B in revenue and converted that into 1.05B in net income, yielding earnings per share of 136.32. EBITDA reached 1.45B, while operating income came in at 1.45B.

Revenue5.78B
Gross Profit2.08B
Operating Income1.45B
Pretax Income1.46B
Net Income1.05B
EBITDA1.45B
EBIT1.45B
Earnings Per Share (EPS)136.32

Balance Sheet

KNC Laboratories Co., Ltd. holds 2.00B in cash and equivalents against 1.97B in total debt, resulting in a net debt position of -30.84M. Total book value stands at 11.00B, with working capital of 4.98B providing operational flexibility.

Cash & Cash Equivalents2.00B
Total Debt1.97B
Net Debt-30.84M
Equity (Book Value)11.00B
Book Value Per Share1,425.40
Working Capital4.98B

Margins

KNC Laboratories Co., Ltd. operates with a gross margin of 35.95, reflecting its pricing power and cost economics. The operating margin of 25.13 and net profit margin of 18.20 provide insight into operational efficiency.

Gross Margin35.95
Operating Margin25.13
Pretax Margin25.20
Profit Margin18.20
EBITDA Margin25.13

Scores

KNC Laboratories Co., Ltd. posts an Altman Z-Score of 2.92, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score2.92